Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2024 Earnings Call Transcript
Operator: Good afternoon. And welcome to Cumberland Pharmaceuticals Third Quarter 2024 Financial Report and Company Update.
Cumberland Pharmaceuticals Inc (CPIX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 528,163 | $676,049 | -2% | 0% |
| 2. | 44,200 | $56,576 | +83% | 0% | |
| 3. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 10,000 | $12,800 | 0% | |
| 4. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.35 | 2 | Director | 29,818 | 2024-12-20 | Filing | |
| $2.33 | 4 | Director | 29,816 | 2024-12-19 | Filing | |
| $2.19 | 10 | Director | 29,812 | 2024-12-18 | Filing | |
| $2.12 | 10 | Director | 29,802 | 2024-12-17 | Filing | |
| $2.21 | 10 | Director | 29,792 | 2024-12-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.79 | 1,000 | Director | 0 | 2019-12-04 | Filing | |
| $5.31 | 3,470 | Director | 1,000 | 2019-09-25 | Filing | |
| $5.27 | 4,400 | Director | 4,470 | 2019-09-23 | Filing | |
| $5.31 | 3,700 | Director | 8,870 | 2019-09-20 | Filing | |
| $5.21 | 4,000 | Director | 12,170 | 2019-09-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 374,251 | $670,546 | 0% | |
| 2. | 365,934 | $636,725 | 0% | |
| 3. | 286,655 | $498,780 | 0.01% | |
| 4. | 110,990 | $198,860 | 0% | |
| 5. | 85,274 | $148,397 | 0% |
News See All
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q2 2024 Earnings Call Transcript
Operator: Good afternoon. And welcome to Cumberland Pharmaceuticals Second Quarter 2024 Financial Report and Company Update.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals First Quarter 2024 Financial Report and Company Update.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals 2023 Financial Report and Company Update.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals Third Quarter 2023 Company Update and Financial Report.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Cumberland Pharmaceuticals' Second Quarter 2023 Company Update and Financial Report.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals First Quarter 2023 Company Update and Financial Report.
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals' 2022 Financial Report and Company Update.
Cumberland Pharmaceuticals, Inc. (CPIX): Are Hedge Funds Right About This Stock?
A whopping number of 13F filings filed with U.S.
Where Do Hedge Funds Stand On Cumberland Pharmaceuticals, Inc. (CPIX)?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September...
Billionaire Hedge Funds
